Bupivacaine hydrochloride is a long-acting local or regional anesthesia used for surgical procedures.
Claris currently has 15 drug approvals, with 25 pending. The company expects more market approvals before the end of the year.
More articles on the drug market:
FDA expedites Merck’s experimental Ebola vaccine
Pills laced with fentanyl invade drug market
Patients in Texas and Florida gain easier access to opioid-overdose antidote naloxone
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.